WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2015> 26> 4

Volume: 26 Issue: 4

1. Surgical staging of para-aortic LN in patients with locally advanced cervix cancer and no evidence of metastases in preoperative PET/CT imaging. Page:352—354
2. Fertility-sparing surgery in high-risk ovarian cancer. Page:350—351
3. Controversies in borderline ovarian tumors. Page:343—349
4. Role of aggressive surgical cytoreduction in advanced ovarian cancer. Page:336—342
5. Identification of high-affinity VEGFR3-binding peptides through a phage-displayed random peptide library. Page:327—335
6. Clinical application of sartorius tendon transposition during radical vulvectomy: a case control study of 58 cases at a single institution. Page:320—326
7. Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer. Page:311—319
8. Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients. Page:303—310
9. Synchronous and metachronous malignancy in endometrial cancer patients treated in a tertiary care center of Thailand. Page:293—302
10. Adjuvant sequential chemo and radiotherapy improves the oncological outcome in high risk endometrial cancer. Page:284—292
11. Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group. Page:277—283
12. Pulmonary metastasectomy in uterine malignancy: outcomes and prognostic factors. Page:270—276
13. Longer waiting times for early stage cervical cancer patients undergoing radical hysterectomy are associated with diminished long-term overall survival. Page:262—269
14. Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer. Page:255—261
15. A critical assessment on the role of sentinel node mapping in endometrial cancer. Page:252—254
16. Uterine carcinosarcoma/malignant mixed Mullerian tumor incidence is increased in women with breast cancer, but independent of hormone therapy. Page:249—251
17. Wait times from diagnosis to treatment in cancer. Page:246—248
18. Who should be offered non-radical surgery for early-stage cervical cancer?. Page:243—245
19. Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma. Page:355—356